Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Catherine Wei
OpenAlex ID:
A5152369741
PA-322 Open-Label, Single-Arm Phase Ib/II Study of Immune Combination Therapy with Belantamab Mafodotin and Elotuzumab in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
2026
·
Sabrina L. Browning
, Fangyong Li
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
PA-341 Patient-Reported Quality of Life and Real-World Outcomes with Use of Daratumumab Regimens in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: A Multicenter Study
2026
·
Sabrina L. Browning
, Fangyong Li
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
2
Citation count:
H-index:
I10-index:
Year
Topic
Type
